rosiglitazone has been researched along with Hyperhomocysteinemia in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amiri, F; Ebrahimian, T; Iglarz, M; Javeshgani, D; LemariƩ, CA; Paradis, P; Savoia, C; Schiffrin, EL | 1 |
Kaur, T; Pal Singh, A; Singh Bedi, PM; Singh, N; SinghDahiya, R | 1 |
Jaggi, AS; Sain, H; Sharma, B; Singh, N | 1 |
Hayden, MR | 1 |
4 other study(ies) available for rosiglitazone and Hyperhomocysteinemia
Article | Year |
---|---|
Countervailing vascular effects of rosiglitazone in high cardiovascular risk mice: role of oxidative stress and PRMT-1.
Topics: Animals; Carotid Artery, Internal; Cholesterol; Cholesterol, Dietary; Disease Models, Animal; Drug Evaluation, Preclinical; Endothelium, Vascular; Female; Hyperhomocysteinemia; Methylenetetrahydrofolate Reductase (NADPH2); Mice; Mice, Knockout; Nitrites; Oxidative Stress; Protein-Arginine N-Methyltransferases; Rosiglitazone; Superoxides; Thiazolidinediones | 2010 |
Ameliorative role of rosiglitazone in hyperhomocysteinemia-induced experimental cardiac hypertrophy.
Topics: Animals; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Fibrosis; Homocysteine; Hyperhomocysteinemia; Hypertrophy, Left Ventricular; Male; Methionine; Oxidative Stress; PPAR gamma; Rats; Rats, Wistar; Rosiglitazone; Thiazolidinediones | 2010 |
Pharmacological investigations on potential of peroxisome proliferator-activated receptor-gamma agonists in hyperhomocysteinemia-induced vascular dementia in rats.
Topics: Animals; Dementia, Vascular; Disease Models, Animal; Hyperhomocysteinemia; Hypoglycemic Agents; Male; Maze Learning; Pioglitazone; PPAR gamma; Rats; Rats, Wistar; Rosiglitazone; Thiazolidinediones | 2011 |
Homocysteine competes for the peroxisome proliferator-activated receptor nuclear receptors.
Topics: Diabetes Mellitus, Type 2; Diet; Folic Acid; Humans; Hyperhomocysteinemia; Hypoglycemic Agents; Peroxisome Proliferator-Activated Receptors; Rosiglitazone; Thiazolidinediones | 2008 |